公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | CD44s and CD44v8-10 isoforms confer acquired resistance to osimertinib by activating the ErbB3/STAT3 signaling pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; JIN-YUAN SHIH | Life sciences | | | |
2023 | LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis | Chen, Yi-Ling; Liu, Yi-Nan; YEN-TING LIN ; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; CHIA-LANG HSU ; HUEY-DONG WU ; JIN-YUAN SHIH | Journal of biomedical science | 2 | 0 | |
2020 | miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; TZU-HSIU TSAI ; Gow, Chien-Hung; Wang, Hsin-Yi; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | 28 | 26 | |
2020 | MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process | Wang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH | Cancer biomarkers : section A of Disease markers | 25 | 20 | |
2024 | miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 | SHANG-GIN WU ; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; YEN-LIN HUANG ; Hsu, Chia-Lang; Jheng, Han-Nian; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | | | |
2023 | MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis | TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH | Cancer medicine | 0 | 0 | |
2017 | Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C | Chang, Tzu-Hua; Tsai M.-F.; Gow, Chien-Hung; SHANG-GIN WU ; Liu, Yi-Nan; YIH-LEONG CHANG ; SUNG-LIANG YU ; HSING-CHEN TSAI ; Lin, Shih-Wen; Chen, Yen-Wei; Kuo, Po-Yen; PAN-CHYR YANG ; JIN-YUAN SHIH | Cancer letters | 48 | 47 | |